Guardant Health (GH) PT Raised to $42 at TD Cowen
Tweet Send to a Friend
TD Cowen analyst Dan Brennan raised the price target on Guardant Health (NASDAQ: GH) to $42.00 (from $41.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
